MENSANA PHARMA LTD.
Significant control: Lorant Molnar (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Mensana Pharma Ltd.: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Mensana Pharma Ltd. sell?
Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
MENSANA PHARMA LTD. is an active private limited company (company number 06000593) incorporated on 16 November 2006, registered in London. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest small accounts cover the period ending 31 December 2024, showing net assets of £463k and cash of £1.61m, with 1 employee on average. Net assets rose 29% on the prior period (£359k).
By net assets it sits in the top quarter of 435 comparable companies in London (median £2,000, upper quartile £90k).
Ownership and control
- Mr Lorant Molnar
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 16 November 200619 yrs ago
- Next accounts due
- 30 September 202628 days overdue
- Confirmation statement due
- 30 November 2026in 33 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | £463k | £1.61m | £966k | — | — | — | 1 |
| 31 December 2023 | £359k | £2.42m | £354k | — | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £463,392 at 31 December 2024
- Net assets up 10% or more on the prior period+29.1% vs prior period
- Cash at bank of £50,000 or moreCash £1,610,803
- Incorporated five or more years agoIncorporated 16 November 2006
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 33 days
- Next accounts due28 days overdue
- Accounts period endNet assets £463k · small accounts
- Accounts period endNet assets £359k · small accounts
- Incorporated
Similar companies in London
- PROJECT & COMMUNICATIONS LIMITEDLondon · inc. Nov 2006
- AVI BIOPHARMA INTERNATIONAL LIMITEDLondon · inc. Jan 2007
- ALLCURES.COM(2006) LIMITEDLondon · inc. Jan 2007
- CITCO CHEMICALS LTD.London · inc. Sept 2006
- CHANELLE VET U.K. LIMITEDLondon · inc. Apr 2007
- TOTALBAU BIOSCIENCE LTDLondon · inc. May 2007
All companies incorporated on 16 November 2006 · in Nov 2006.
Reminders for MENSANA PHARMA LTD.
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.